AEON Biopharma, Inc.
AEONAMEXHealthcare● Active
$0.74
+$0.02(+2.08%)
Market Cap$8715411
P/E Ratio—
52W High$1.45
52W Low$0.625
AEON Biopharma, Inc.（AEON）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AEON · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.01B | $0.03B | $0.03B | $0.03B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.01B | ($0.07B) | $0.35B | $0.05B | $0.07B |
| Operating Income | ($0.01B) | $0.07B | ($0.35B) | ($0.05B) | ($0.07B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | $0.04B | ($0.38B) | ($0.05B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.04B) | $0.04B | ($0.38B) | ($0.05B) | ($0.06B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.95 | $77.74 | $-4.99 | $-27.25 | $-31.73 |
| Wtd Avg Shares | 0.01B | 0.00B | 0.08B | 0.00B | 0.00B |
| EBITDA | ($0.02B) | ($0.03B) | ($0.05B) | ($0.05B) | ($0.04B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解AEON Biopharma, Inc.
关于AEON Biopharma, Inc.（AEON）损益表
AEON Biopharma, Inc.（AEON）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AEON实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.04B)（净利率—）。
常见问题
AEON · 4 问AEON Biopharma, Inc.（AEON）2025财年营收为$0.00B，同比down—%。
AEON revenueAEON salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09